Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6atac small nuclear 8, pseudogene (RNU6ATAC8P) is a pseudogene related to the U6atac small nuclear RNA, which is itself part of the minor spliceosome, a complex responsible for the splicing of rare minor introns in eukaryotic genes[1]. Pseudogenes are sequences similar to known genes but generally lack the ability to encode functional products. While some pseudogenes can be transcribed and may have regulatory roles, there is currently no evidence that RNU6ATAC8P has a biological function, acts as a biomarker, or is involved in disease. It is not considered a therapeutic target, and no drugs are known to interact with it[4][2]. There are many snRNA pseudogenes in the human genome with unknown function, and most are considered genomic relics without clinical utility[2][4].
Not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6atac small nuclear 8, pseudogene (RNU6ATAC8P).